Excelsior Biopharma Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 345.357 million compared to TWD 345.938 million a year ago. Operating income was TWD 4.231 million compared to TWD 16.298 million a year ago. Net income was TWD 2.571 million compared to TWD 12.616 million a year ago. Basic earnings per share from continuing operations was TWD 0.06 compared to TWD 0.27 a year ago.